NOVONORM Side Effects

7010123-9 | Hypotension
on Sep 13, 2010 Female patient from FRANCE , 88 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension. Novonorm dosage: Uknown/po. During the same period patient was treated with AUGMENTIN '125' (1 G, Tid) (View Augmentin '125' Review and Augmentin '125' Label ), LANTUS (Unk) (View Lantus Review and Lantus Label ), INNOHEP /01707902/ (0.5 Ml, Qd) (View Innohep /01707902/ Review and Innohep /01707902/ Label ), LERCANIDIPINE (10 Mg, Unk) (View Lercanidipine Review and Lercanidipine Label ), ZYLORIC /00003301/ (Unk) (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ), ESOMEPRAZOLE MAGNESIUM (20 Mg, Qd) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), FORLAX (3 Df, Qd) (View Forlax Review and Forlax Label ), CIPROFLOXACIN HCL (250 Mg, Bid) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ). Patient was hospitalized.

7004849-0 | Diabetes Mellitus Inadequate Control, Pancreatic Carcinoma
Patient was taking Novonorm (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, pancreatic carcinoma on Sep 10, 2010 from SWEDEN Additional patient health information: Male patient , 67 years of age, weighting 138.9 lb, was diagnosed with diabetes mellitus, pain (What is pain?) and. Novonorm dosage: 0.5 Mg, Bid. During the same period patient was treated with PANTOLOC /01263201/ (40 Mg, Qd) (View Pantoloc /01263201/ Review and Pantoloc /01263201/ Label ), CREON (10000 Unk, Unk) (View Creon Review and Creon Label ), ZOLPIDEM TARTRATE (5 Mg, Qd) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), NEXIUM (20 Mg, Qd) (View Nexium Review and Nexium Label ), OXYCODONE HCL (5 Mg, Qd) (View Oxycodone Hcl Review and Oxycodone Hcl Label ).

6984693-0 | Gastroenteritis, Hypoglycaemic Coma
Adverse event was reported on Sep 08, 2010 by a Female patient taking Novonorm (View Usage) (Dosage: 6 Mg, Qd) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 90 years of age, After Novonorm was administered, patient had the following side effects: gastroenteritis (What is gastroenteritis?), hypoglycaemic coma. During the same period patient was treated with HYPERIUM /00939801/ (2 Mg, Qd) (View Hyperium /00939801/ Review and Hyperium /00939801/ Label ), ISOPTIN (240 Mg, Qd) (View Isoptin Review and Isoptin Label ), DIOSMINE (Unk) (View Diosmine Review and Diosmine Label ), DEBRIDAT /00465201/ (Unk) (View Debridat /00465201/ Review and Debridat /00465201/ Label ). Patient was hospitalized.

6978245-6 | Abdominal Wall Haematoma, Cardiac Failure, Haemorrhagic Stroke, Nutritional Condition Abnormal, Renal Failure Acute, Urinary Tract Infection
on Aug 31, 2010 Female patient from FRANCE , 88 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, arrhythmia (What is arrhythmia?) and was treated with Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal wall haematoma, cardiac failure, haemorrhagic stroke, nutritional condition abnormal, renal failure acute, urinary tract infection (What is urinary tract infection?). Novonorm dosage: Uk/po. During the same period patient was treated with VITAMIN K ANTAGONISTS (View Vitamin K Antagonists Review and Vitamin K Antagonists Label ), LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), LOXEN (View Loxen Review and Loxen Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), CORDARONE (View Cordarone Review and Cordarone Label ), NEO MERCAZOLE TAB (View Neo-mercazole Tab Review and Neo-mercazole Tab Label ), COZAAR (50 Mg, Qd) (View Cozaar Review and Cozaar Label ), SINTROM (Unk) (View Sintrom Review and Sintrom Label ). Patient was hospitalized.


6907667-4 | Anaemia Haemolytic Autoimmune
on Jul 28, 2010 Female patient from FRANCE , 73 years of age, was diagnosed with type 2 diabetes mellitus, insomnia and was treated with Novonorm (View Usage). Patient had the following side effects: anaemia haemolytic autoimmune. Novonorm dosage: Unk. During the same period patient was treated with INEXIUM /01479302/ (80 Mg, Qd) (View Inexium /01479302/ Review and Inexium /01479302/ Label ), AVLOCARDYL /00030001/ (160 Mg, Qd) (View Avlocardyl /00030001/ Review and Avlocardyl /00030001/ Label ), IMOVANE (3.75 Mg, Qd) (View Imovane Review and Imovane Label ), XANAX (0.25 Mg, Qd) (View Xanax Review and Xanax Label ). Patient was hospitalized.

6886956-6 | Hypotension
Patient was taking Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: hypotension on Jul 22, 2010 from FRANCE Additional patient health information: Female patient , 88 years of age, was diagnosed with type 2 diabetes mellitus and. Novonorm dosage: Uknown/po. During the same period patient was treated with AUGMENTIN '125' (1 G, Tid) (View Augmentin '125' Review and Augmentin '125' Label ), LANTUS (Unk) (View Lantus Review and Lantus Label ), INNOHEP /01707902/ (0.5 Ml, Qd) (View Innohep /01707902/ Review and Innohep /01707902/ Label ), LERCAN (10 Mg, Unk) (View Lercan Review and Lercan Label ), ZYLORIC /00003301/ (Unk) (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ), ESOMEPRAZOLE MAGNESIUM (20 Mg, Qd) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), FORLAX (3 Df, Qd) (View Forlax Review and Forlax Label ), CIPROFLOXACIN HCL (250 Mg, Bid) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ). Patient was hospitalized.

6886954-2 | Aphasia, Hypoglycaemia
Adverse event was reported on May 17, 2010 by a Male patient taking Novonorm (View Usage) (Dosage: 1 Mg, Tid) was diagnosed with diabetes mellitus, urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 76 years of age, Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), hypoglycaemia. During the same period patient was treated with BACTRIM (160 Mg/ 800 Mg, Qd) (View Bactrim Review and Bactrim Label ), INEXIUM /01479302/ (View Inexium /01479302/ Review and Inexium /01479302/ Label ), COVERSYL /00790701/ (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), CORDARONE (View Cordarone Review and Cordarone Label ), AMIODARONE HCL (200 Mg, Qd) (View Amiodarone Hcl Review and Amiodarone Hcl Label ), PERINDOPRIL (2 Mg, Qd) (View Perindopril Review and Perindopril Label ), FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), ESOMEPRAZOLE MAGNESIUM (20 Mg, Qd) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

6886946-3 | Condition Aggravated, Cytolytic Hepatitis
on Jul 22, 2010 Female patient from FRANCE , 46 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novonorm (View Usage). Patient had the following side effects: condition aggravated, cytolytic hepatitis. Novonorm dosage: 5 Mg - 4 Mg - 2 Mg. During the same period patient was treated with IMUREL /00001501/ (From 50 Mg To 100 Mg To 150 Mg) (View Imurel /00001501/ Review and Imurel /00001501/ Label ), CORTANCYL (60mg) (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6871850-7 | Anaemia
on Jul 12, 2010 Male patient from CHINA , 84 years of age, was diagnosed with diabetes mellitus and was treated with Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: anaemia. Novonorm dosage: . During the same period patient was treated with AVANDIA (Unk) (View Avandia Review and Avandia Label ), GLUCOBAY (Unk) (View Glucobay Review and Glucobay Label ). Patient was hospitalized.

6860011-3 | Infection, Overdose, Somnolence, Transaminases Increased
Patient was taking Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?), overdose, somnolence, transaminases increased on Jul 09, 2010 from GERMANY Additional patient health information: Female patient , 70 years of age, weighting 99.21 lb, was diagnosed with type 2 diabetes mellitus, restless legs syndrome, hypertension, prophylaxis against gastrointestinal ulcer, dyslipidaemia, osteoporosis (What is osteoporosis?), pain (What is pain?), vitamin supplementation and. Novonorm dosage: 2 Mg, Tid. During the same period patient was treated with LEVODOPA BENSERAZIDE HYDROCHLO (1 Df, Qd) (View Levodopa Benserazide Hydrochlo Review and Levodopa Benserazide Hydrochlo Label ), CARVEDILOL 1A PHARMA (12.5 Mg, Qd) (View Carvedilol 1a Pharma Review and Carvedilol 1a Pharma Label ), BLOPRESS (8 Mg, Qd) (View Blopress Review and Blopress Label ), OMEPRAZOL 1A PHARMA GMBH (40 Mg, Qd) (View Omeprazol 1a Pharma Gmbh Review and Omeprazol 1a Pharma Gmbh Label ), SIMVASTATIN (10 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), ACTONEL (35 Mg, Qd) (View Actonel Review and Actonel Label ), FENTANYL HEXAL (50ug/hour) (View Fentanyl Hexal Review and Fentanyl Hexal Label ), DREISAVIT /00844801/ (1 Df, Qd) (View Dreisavit /00844801/ Review and Dreisavit /00844801/ Label ). Patient was hospitalized.

6831607-X | Somnolence, Transaminases Increased
Adverse event was reported on Jun 29, 2010 by a Female patient taking Novonorm (View Usage) (Dosage: Unk) was diagnosed with type 2 diabetes mellitus, pain (What is pain?), vitamin supplementation, renal failure, coronary artery disease (What is coronary artery disease?), nausea (What is nausea?), restless legs syndrome and. Location: GERMANY , 70 years of age, weighting 99.21 lb, Patient had the following side effects: somnolence, transaminases increased. During the same period patient was treated with FENTANYL (Unk) (View Fentanyl Review and Fentanyl Label ), DREISAVIT /00844801/ (Unk) (View Dreisavit /00844801/ Review and Dreisavit /00844801/ Label ), FOSRENOL (Unk) (View Fosrenol Review and Fosrenol Label ), DIGITOXIN (Unk) (View Digitoxin Review and Digitoxin Label ), MCP /00041901/ (Unk) (View Mcp /00041901/ Review and Mcp /00041901/ Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), METAMIZOLE (Unk) (View Metamizole Review and Metamizole Label ), RESTEX (Unk) (View Restex Review and Restex Label ). Patient was hospitalized.

6822226-X | Anaemia Haemolytic Autoimmune
on Jun 30, 2010 Female patient from FRANCE , 73 years of age, was diagnosed with type 2 diabetes mellitus, insomnia and was treated with Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: anaemia haemolytic autoimmune. Novonorm dosage: Unk. During the same period patient was treated with INEXIUM /01479302/ (80 Mg, Qd) (View Inexium /01479302/ Review and Inexium /01479302/ Label ), AVLOCARDYL /00030001/ (160 Mg, Qd) (View Avlocardyl /00030001/ Review and Avlocardyl /00030001/ Label ), IMOVANE (3.75 Mg, Qd) (View Imovane Review and Imovane Label ), XANAX (0.25 Mg, Unk) (View Xanax Review and Xanax Label ). Patient was hospitalized.

6790121-0 | Vasculitis
on Jun 16, 2010 Male patient from FRANCE , 67 years of age, weighting 191.8 lb, was diagnosed with type 2 diabetes mellitus, hypertension, dyslipidaemia and was treated with Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: vasculitis (What is vasculitis?). Novonorm dosage: 3 Mg, Qd. During the same period patient was treated with NISISCO (Uk/po) (View Nisisco Review and Nisisco Label ), LERCAN (20 Mg, Qd) (View Lercan Review and Lercan Label ), AVLOCARDYL /00030001/ (80 Mg, Qd) (View Avlocardyl /00030001/ Review and Avlocardyl /00030001/ Label ), TAHOR (10 Mg, Qd) (View Tahor Review and Tahor Label ), ZYLORIC /00003301/ (100 Mg, Qd) (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ), DIAMICRON (30 Mg, Qd) (View Diamicron Review and Diamicron Label ), KARDEGIC /01740801/ (75 Mg, Qd) (View Kardegic /01740801/ Review and Kardegic /01740801/ Label ), PREVISCAN /00261401/ (Uk/po) (View Previscan /00261401/ Review and Previscan /00261401/ Label ). Patient was hospitalized.

6763513-3 | Diabetes Mellitus Inadequate Control, Pancreatic Carcinoma
Patient was taking Novonorm (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, pancreatic carcinoma on Jun 03, 2010 from SWEDEN Additional patient health information: Male patient , 67 years of age, weighting 138.9 lb, was diagnosed with diabetes mellitus, pain (What is pain?) and. Novonorm dosage: 0.5 Mg, Bid. During the same period patient was treated with PANTOLOC /01263201/ (40 Mg, Qd) (View Pantoloc /01263201/ Review and Pantoloc /01263201/ Label ), CREON (10000 Unk, Unk) (View Creon Review and Creon Label ), STILNOCT (5 Mg, Qd) (View Stilnoct Review and Stilnoct Label ), NEXIUM (20 Mg, Qd) (View Nexium Review and Nexium Label ), OXYCODONE HCL (5 Mg, Qd) (View Oxycodone Hcl Review and Oxycodone Hcl Label ).

6723608-7 | Cardiac Failure, Hyperthyroidism, Multi-organ Failure, Renal Failure
Adverse event was reported on May 07, 2010 by a Female patient taking Novonorm (View Usage) (Dosage: Uk) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 83 years of age, After Novonorm was administered, patient had the following side effects: cardiac failure, hyperthyroidism, multi-organ failure, renal failure. During the same period patient was treated with CORDARONE (200 Mg, Qd) (View Cordarone Review and Cordarone Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), DIFFU K (View Diffu K Review and Diffu K Label ), PREVISCAN /00261401/ (View Previscan /00261401/ Review and Previscan /00261401/ Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NOVOMIX 30 (View Novomix 30 Review and Novomix 30 Label ). Patient was hospitalized.

6719136-5 | Vasculitis
on Apr 30, 2010 Male patient from FRANCE , 67 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, dyslipidaemia and was treated with Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: vasculitis (What is vasculitis?). Novonorm dosage: 3 Mg, Qd. During the same period patient was treated with NISISCO (Uk/po) (View Nisisco Review and Nisisco Label ), LERCAN (20 Mg, Qd) (View Lercan Review and Lercan Label ), AVLOCARDYL /00030001/ (80 Mg, Qd) (View Avlocardyl /00030001/ Review and Avlocardyl /00030001/ Label ), TAHOR (10 Mg, Qd) (View Tahor Review and Tahor Label ), ZYLORIC /00003301/ (100 Mg, Qd) (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ), DIAMICRON (30 Mg, Qd) (View Diamicron Review and Diamicron Label ), KARDEGIC /01740801/ (75 Mg, Qd) (View Kardegic /01740801/ Review and Kardegic /01740801/ Label ), GLUCOPHAGE (3 G, Qd) (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

6702805-0 | Dysphagia, Localised Oedema, Tongue Oedema
on Apr 23, 2010 Female patient from FRANCE , 89 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, myocardial ischaemia, goitre and was treated with Novonorm (View Usage). Patient had the following side effects: dysphagia, localised oedema, tongue oedema. Novonorm dosage: 2 Mg Morning And Evening And 1 Mg At Noon. During the same period patient was treated with RENNIE /00219301/ (3 Tab, Qd) (View Rennie /00219301/ Review and Rennie /00219301/ Label ), COVERSYL /00790701/ (4 Mg, Qd) (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), FLUDEX /00340101/ (1.5 Mg, Qd) (View Fludex /00340101/ Review and Fludex /00340101/ Label ), TAHOR (40 Mg, Qd) (View Tahor Review and Tahor Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), ZOPICLONE (1 Tab, Qd At Bedtime) (View Zopiclone Review and Zopiclone Label ), CELIPROLOL (200 Mg, Qd) (View Celiprolol Review and Celiprolol Label ), LEVOTHYROX (25 Ug, Qd) (View Levothyrox Review and Levothyrox Label ). Patient was hospitalized.

6694387-7 | Dysphagia, Localised Oedema, Tongue Oedema
Patient was taking Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: dysphagia, localised oedema, tongue oedema on Apr 13, 2010 from FRANCE Additional patient health information: Female patient , 89 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, myocardial ischaemia, goitre and. Novonorm dosage: 2 Mg Morning And Evening And 1 Mg At Noon. During the same period patient was treated with RENNIE /00219301/ (3 Tab, Unk) (View Rennie /00219301/ Review and Rennie /00219301/ Label ), COVERSYL /00790701/ (4 Mg, Qd) (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), FLUDEX /00340101/ (1.5 Mg, Qd) (View Fludex /00340101/ Review and Fludex /00340101/ Label ), TAHOR (40 Mg, Qd) (View Tahor Review and Tahor Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), ZOPICLONE (1 Tab, Qd At Bedtime) (View Zopiclone Review and Zopiclone Label ), CELIPROLOL (200 Mg, Qd) (View Celiprolol Review and Celiprolol Label ), LEVOTHYROX (25 Ug, Qd) (View Levothyrox Review and Levothyrox Label ). Patient was hospitalized.

6692785-9 | Hepatitis Toxic
Adverse event was reported on Apr 15, 2010 by a Male patient taking Novonorm (View Usage) (Dosage: Unk, Prn) was diagnosed with type 2 diabetes mellitus, pneumonia (What is pneumonia?), oesophageal candidiasis and. Location: GERMANY , weighting 174.2 lb, Patient experienced the following unwanted or unexpected effects: hepatitis toxic. During the same period patient was treated with AVELOX (400 Mg, Qd) (View Avelox Review and Avelox Label ), DIFLUCAN (Unk Caps, Prn) (View Diflucan Review and Diflucan Label ), NEXIUM (Unk, Prn) (View Nexium Review and Nexium Label ), DECORTIN H (Unk, Prn) (View Decortin H Review and Decortin H Label ). Patient was hospitalized.

6687875-0 | Somnolence, Transaminases Increased
on Apr 09, 2010 Female patient from GERMANY , 70 years of age, weighting 99.21 lb, was diagnosed with type 2 diabetes mellitus, restless legs syndrome, hypertension, prophylaxis against gastrointestinal ulcer, dyslipidaemia, osteoporosis (What is osteoporosis?), pain (What is pain?), vitamin supplementation and was treated with Novonorm (View Usage). Patient had the following side effects: somnolence, transaminases increased. Novonorm dosage: 2 Mg, Tid. During the same period patient was treated with LEVODOPA BENSERAZIDE HYDROCHLO (1 Df, Qd) (View Levodopa Benserazide Hydrochlo Review and Levodopa Benserazide Hydrochlo Label ), CARVEDILOL 1A PHARMA (12.5 Mg, Qd) (View Carvedilol 1a Pharma Review and Carvedilol 1a Pharma Label ), CANDESARTAN CILEXETIL (8 Mg, Qd) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), OMEPRAZOL 1A PHARMA GMBH (40 Mg, Qd) (View Omeprazol 1a Pharma Gmbh Review and Omeprazol 1a Pharma Gmbh Label ), SIMVASTATIN (10 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), ACTONEL (35 Mg, Qd) (View Actonel Review and Actonel Label ), FENTANYL HEXAL (50ug/hour) (View Fentanyl Hexal Review and Fentanyl Hexal Label ), DREISAVIT /00844801/ (1 Df, Qd) (View Dreisavit /00844801/ Review and Dreisavit /00844801/ Label ). Patient was hospitalized.

6676536-X | Pregnancy
on Apr 01, 2010 Female patient from SWITZERLAND , 31 years of age, was treated with Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: pregnancy (What is pregnancy?). Novonorm dosage: As Necessary / Transplacental. During the same period patient was treated with MINERVA /00541901/ (1 Dosage Form / Transplacental) (View Minerva /00541901/ Review and Minerva /00541901/ Label ), LEXOTANIL (As Necessary / Transplacental) (View Lexotanil Review and Lexotanil Label ), TRYPTIZOL /00002202/ (As Necessary / Transplacental) (View Tryptizol /00002202/ Review and Tryptizol /00002202/ Label ), CORGARD (As Necessary / Transplacental) (View Corgard Review and Corgard Label ), RIMACTAN /00146901/ (As Necessary / Transplacental) (View Rimactan /00146901/ Review and Rimactan /00146901/ Label ), BACTRIM (As Necessary / Transplacental) (View Bactrim Review and Bactrim Label ), RELPAX (As Necessary / Transplacental) (View Relpax Review and Relpax Label ), TOPAMAX (As Necessary / Transplacental) (View Topamax Review and Topamax Label ).

6642596-5 | Cytolytic Hepatitis
Patient was taking Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis on Mar 09, 2010 from FRANCE Additional patient health information: Male patient , 78 years of age, was diagnosed with type 2 diabetes mellitus, hiv infection (What is hiv infection?), gout (What is gout?) and. Novonorm dosage: 1 Mg, Qd. During the same period patient was treated with KALETRA (4 Pharmaceutical Doses) (View Kaletra Review and Kaletra Label ), KIVEXA (900 Mg, Qd) (View Kivexa Review and Kivexa Label ), ZYLORIC (Uk) (View Zyloric Review and Zyloric Label ), COLCHIMAX (Unk) (View Colchimax Review and Colchimax Label ). Patient was hospitalized.

6634043-4 | Abdominal Pain, Diarrhoea
Adverse event was reported on Mar 05, 2010 by a Male patient taking Novonorm (View Usage) (Dosage: Unk) was diagnosed with diabetes mellitus and. Location: FRANCE , 51 years of age, weighting 147.7 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea. During the same period patient was treated with CELLCEPT (500 Mg, Qd) (View Cellcept Review and Cellcept Label ), RAPAMUNE (Unk) (View Rapamune Review and Rapamune Label ), CORTANCYL (Unk) (View Cortancyl Review and Cortancyl Label ), OXYCODONE HCL (Unk) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), METHADONE HYDROCHLORIDE (Unk) (View Methadone Hydrochloride Review and Methadone Hydrochloride Label ), ORACILLINE /00001801/ (Unk) (View Oracilline /00001801/ Review and Oracilline /00001801/ Label ), ZELITREX /01269701/ (Unk) (View Zelitrex /01269701/ Review and Zelitrex /01269701/ Label ). Patient was hospitalized.

6631740-1 | Asthenia, Diarrhoea, Hypoglycaemia, Renal Failure, Vertigo
on Mar 03, 2010 Female patient from FRANCE , 78 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: asthenia, diarrhoea, hypoglycaemia, renal failure, vertigo. Novonorm dosage: 4 Mg, Qd. During the same period patient was treated with SOTALEX (160 Mg, Qd) (View Sotalex Review and Sotalex Label ), ALDACTONE (75 Mg, Qd) (View Aldactone Review and Aldactone Label ), HYDERGINE /00436902/ (View Hydergine /00436902/ Review and Hydergine /00436902/ Label ), VASTAREL (35 Mg, Qd) (View Vastarel Review and Vastarel Label ), PLAVIX (Uk) (View Plavix Review and Plavix Label ), SPECIAFOLDINE (Uk) (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

6615221-7 | Cytolytic Hepatitis
on Feb 25, 2010 Female patient from SPAIN , 75 years of age, was diagnosed with diabetes mellitus, hypertension, dyslipidaemia and was treated with Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. Novonorm dosage: 6 Mg, Qd. During the same period patient was treated with IBUPROFEN (1.8 G, Qd) (View Ibuprofen Review and Ibuprofen Label ), NIFEDIPINE (30 Mg, Qd) (View Nifedipine Review and Nifedipine Label ), OLMESARTAN MEDOXOMIL (20 Mg, Qd) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ATORVASTATIN CALCIUM (40 Mg, Qd) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

6615219-9 | Abdominal Wall Haematoma, Cardiac Failure, Haemorrhagic Stroke, Nutritional Condition Abnormal, Renal Failure Acute, Urinary Tract Infection
Patient was taking Novonorm (View Usage). Patient had the following side effects: abdominal wall haematoma, cardiac failure, haemorrhagic stroke, nutritional condition abnormal, renal failure acute, urinary tract infection (What is urinary tract infection?) on Feb 24, 2010 from FRANCE Additional patient health information: Female patient , 88 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, arrhythmia (What is arrhythmia?) and. Novonorm dosage: Uk/po. During the same period patient was treated with VITAMIN K ANTAGONISTS (View Vitamin K Antagonists Review and Vitamin K Antagonists Label ), LASIX (View Lasix Review and Lasix Label ), LOXEN (View Loxen Review and Loxen Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), CORDARONE (View Cordarone Review and Cordarone Label ), NEO MERCAZOLE TAB (View Neo-mercazole Tab Review and Neo-mercazole Tab Label ), COZAAR (50 Mg, Qd) (View Cozaar Review and Cozaar Label ), SINTROM (Unk) (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

6584885-9 | Abdominal Pain, Diarrhoea
Adverse event was reported on Feb 05, 2010 by a Male patient taking Novonorm (View Usage) (Dosage: Unk) . Location: FRANCE , 51 years of age, After Novonorm was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea. During the same period patient was treated with CELLCEPT (500 Mg, Qd) (View Cellcept Review and Cellcept Label ), RAPAMUNE (Unk) (View Rapamune Review and Rapamune Label ), CORTANCYL (Unk) (View Cortancyl Review and Cortancyl Label ), OXYNORM (Unk) (View Oxynorm Review and Oxynorm Label ), METHADONE HCL (Unk) (View Methadone Hcl Review and Methadone Hcl Label ), ORACILLINE /00001801/ (Unk) (View Oracilline /00001801/ Review and Oracilline /00001801/ Label ), ZELITREX /01269701/ (Unk) (View Zelitrex /01269701/ Review and Zelitrex /01269701/ Label ). Patient was hospitalized.

6579127-4 | Abdominal Wall Haematoma, Cardiac Failure, Haemorrhagic Stroke, Nutritional Condition Abnormal, Renal Failure Acute, Urinary Tract Infection
on Feb 02, 2010 Female patient from FRANCE , 88 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, arrhythmia (What is arrhythmia?) and was treated with Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal wall haematoma, cardiac failure, haemorrhagic stroke, nutritional condition abnormal, renal failure acute, urinary tract infection (What is urinary tract infection?). Novonorm dosage: Uk/po. During the same period patient was treated with VITAMIN K ANTAGONISTS (View Vitamin K Antagonists Review and Vitamin K Antagonists Label ), LASIX (View Lasix Review and Lasix Label ), LOXEN (View Loxen Review and Loxen Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), CORDARONE (View Cordarone Review and Cordarone Label ), NEO MERCAZOLE TAB (View Neo-mercazole Tab Review and Neo-mercazole Tab Label ), COZAAR (50 Mg, Qd) (View Cozaar Review and Cozaar Label ), SINTROM (Unk) (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

6579124-9 | Asthenia, Diarrhoea, Hypoglycaemia, Vertigo
on Feb 01, 2010 Female patient from FRANCE , 78 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novonorm (View Usage). Patient had the following side effects: asthenia, diarrhoea, hypoglycaemia, vertigo. Novonorm dosage: 4 Mg, Qd. During the same period patient was treated with SOTALEX (160 Mg, Qd) (View Sotalex Review and Sotalex Label ), ALDACTONE (75 Mg, Qd) (View Aldactone Review and Aldactone Label ), HYDERGINE /00436902/ (View Hydergine /00436902/ Review and Hydergine /00436902/ Label ), VASTAREL (35 Mg, Qd) (View Vastarel Review and Vastarel Label ), PLAVIX (Uk) (View Plavix Review and Plavix Label ), SPECIAFOLDINE (Uk) (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

6577090-3 | Dialysis, Disorientation, Loss Of Consciousness, Overdose, Somnolence, Transaminases Increased
Patient was taking Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: dialysis (What is dialysis?), disorientation, loss of consciousness, overdose, somnolence, transaminases increased on Feb 01, 2010 from GERMANY Additional patient health information: Female patient , 70 years of age, weighting 99.21 lb, was diagnosed with type 2 diabetes mellitus and. Novonorm dosage: Unk. During the same period patient was treated with FENTANYL 100 (Unk) (View Fentanyl-100 Review and Fentanyl-100 Label ), DREISAVIT /00844801/ (Unk) (View Dreisavit /00844801/ Review and Dreisavit /00844801/ Label ), FOSRENOL (Unk) (View Fosrenol Review and Fosrenol Label ), DIGITOXIN (Unk) (View Digitoxin Review and Digitoxin Label ), MCP /00041901/ (Unk) (View Mcp /00041901/ Review and Mcp /00041901/ Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), METAMIZOLE (Unk) (View Metamizole Review and Metamizole Label ), RESTEX (Unk) (View Restex Review and Restex Label ). Patient was hospitalized.

6569050-3 | Angioedema
Adverse event was reported on Jan 27, 2010 by a Female patient taking Novonorm (View Usage) (Dosage: 1 Unk, Bid) was diagnosed with type 2 diabetes mellitus and. Location: GERMANY , 73 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: angioedema. During the same period patient was treated with ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), RAMIPRIL (10 Mg, Qd) (View Ramipril Review and Ramipril Label ), AMLODIPIN /00972401/ (5 Mg, Qd) (View Amlodipin /00972401/ Review and Amlodipin /00972401/ Label ), L THYROXIN (125 Ug, Qd) (View L-thyroxin Review and L-thyroxin Label ), NEBILET (2.5 Mg, Qd) (View Nebilet Review and Nebilet Label ). Patient was hospitalized.

6555494-2 |
on Jan 19, 2010 Male patient from FRANCE , 80 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novonorm (View Usage). . Novonorm dosage: 1 Mg, Qd. During the same period patient was treated with ENANTONE /00726901/ (30 Mg Per 3 Months) (View Enantone /00726901/ Review and Enantone /00726901/ Label ), COMTAN (1000 Mg, Qd) (View Comtan Review and Comtan Label ), MODOPAR (625 Mg, Qd) (View Modopar Review and Modopar Label ), COZAAR (50 Mg, Qd) (View Cozaar Review and Cozaar Label ), METFORMIN HCL (2000 Mg, Qd) (View Metformin Hcl Review and Metformin Hcl Label ), TAHOR (10 Mg, Qd) (View Tahor Review and Tahor Label ), EQUANIL (500 Mg, Qd) (View Equanil Review and Equanil Label ), ATHYMIL (30 Mg, Qd) (View Athymil Review and Athymil Label ).

6532679-2 | Cytolytic Hepatitis
on Dec 29, 2009 Male patient from FRANCE , 78 years of age, was diagnosed with type 2 diabetes mellitus, hiv infection (What is hiv infection?), gout (What is gout?) and was treated with Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: cytolytic hepatitis. Novonorm dosage: 1 Mg, Qd. During the same period patient was treated with KALETRA (4 Pharmaceutical Doses) (View Kaletra Review and Kaletra Label ), KIVEXA (900 Mg, Qd) (View Kivexa Review and Kivexa Label ), ZYLORIC /00003301/ (Uk) (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ), COLCHIMAX (Unk) (View Colchimax Review and Colchimax Label ). Patient was hospitalized.

6529450-4 | Dysarthria, Hypoglycaemia
Patient was taking Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: dysarthria, hypoglycaemia on Dec 29, 2009 from FRANCE Additional patient health information: Female patient , 74 years of age, was diagnosed with type 2 diabetes mellitus and. Novonorm dosage: 1 Mg, Tid. During the same period patient was treated with COKENZEN (View Cokenzen Review and Cokenzen Label ), ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ), PREVISCAN /00261401/ (View Previscan /00261401/ Review and Previscan /00261401/ Label ), CRESTOR (View Crestor Review and Crestor Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), STABLON /00956301/ (View Stablon /00956301/ Review and Stablon /00956301/ Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6527738-4 | Pneumonia
Adverse event was reported on Nov 26, 2009 by a Male patient taking Novonorm (View Usage) (Dosage: Unk) was diagnosed with type 2 diabetes mellitus and. Location: SPAIN , 59 years of age, weighting 185.2 lb, Patient had the following side effects: pneumonia (What is pneumonia?). During the same period patient was treated with PROTAPHANE PENFILL (View Protaphane Penfill Review and Protaphane Penfill Label ), ATORVASTATIN CALCIUM (20 Mg, Qd) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), IRBESARTAN (150 Mg, Qd) (View Irbesartan Review and Irbesartan Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), HIDROCLOROTIAZIDE (12.5 Mg, Qd) (View Hidroclorotiazide Review and Hidroclorotiazide Label ). Patient was hospitalized.

6518613-X | Hypokalaemia, Somnolence
on Dec 10, 2009 Female patient from FRANCE , 82 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: hypokalaemia, somnolence. Novonorm dosage: Uk. During the same period patient was treated with FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), MEDIATOR (150 Mg, Unk) (View Mediator Review and Mediator Label ), TAREG (160 Mg, Unk) (View Tareg Review and Tareg Label ), LOXEN (20 Mg, Unk) (View Loxen Review and Loxen Label ), LEVOTHYROXINE SODIUM (125 Ug, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), KARDEGIC /00002703/ (160 Mg, Unk) (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ). Patient was hospitalized.

6516231-0 | Cardiac Failure, Hyperthyroidism, Renal Failure
on Dec 15, 2009 Female patient from FRANCE , 83 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, hyperthyroidism, renal failure. Novonorm dosage: Uk. During the same period patient was treated with CORDARONE (200 Mg, Qd) (View Cordarone Review and Cordarone Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), DIFFU K (View Diffu K Review and Diffu K Label ), PREVISCAN /00261401/ (View Previscan /00261401/ Review and Previscan /00261401/ Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NOVOMIX 30 (View Novomix 30 Review and Novomix 30 Label ). Patient was hospitalized.

6503677-X | Hypokalaemia, Somnolence
Patient was taking Novonorm (View Usage). Patient had the following side effects: hypokalaemia, somnolence on Dec 10, 2009 from FRANCE Additional patient health information: Female patient , 82 years of age, was diagnosed with type 2 diabetes mellitus and. Novonorm dosage: Uk. During the same period patient was treated with FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), MEDIATOR (150 Mg, Unk) (View Mediator Review and Mediator Label ), TAREG (160 Mg, Unk) (View Tareg Review and Tareg Label ), LOXEN (20 Mg, Unk) (View Loxen Review and Loxen Label ), LEVOTHYROXINE SODIUM (125 Ug, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), KARDEGIC /00002703/ (160 Mg, Unk) (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ). Patient was hospitalized.

6497895-7 | Blood Glucose Increased, Haematocrit Decreased, Haemodialysis, Haemoglobin Decreased, Nausea, Renal Failure, White Blood Cell Count Increased
Adverse event was reported on Dec 04, 2009 by a Female patient taking Novonorm (View Usage) (Dosage: 2 Mg, Tid) was diagnosed with type 2 diabetes mellitus and. Location: GERMANY , 77 years of age, weighting 145.5 lb, After Novonorm was administered, patient had the following side effects: blood glucose increased, haematocrit decreased, haemodialysis, haemoglobin decreased, nausea (What is nausea?), renal failure, white blood cell count increased. During the same period patient was treated with DELIX /00885601/ (2.5 Mg, Qd) (View Delix /00885601/ Review and Delix /00885601/ Label ), DIURAPID (40 Mg, Qd) (View Diurapid Review and Diurapid Label ), LEVEMIR (16 Unk, Unk) (View Levemir Review and Levemir Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), CONCOR /00802601/ (5 Mg, Qd) (View Concor /00802601/ Review and Concor /00802601/ Label ), OMEPRAZOL /00661201/ (20 Mg, Qd) (View Omeprazol /00661201/ Review and Omeprazol /00661201/ Label ), SIMVASTATIN (20 Mg, Qd) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6491042-3 | Macular Oedema
on Dec 02, 2009 Male patient from FRANCE , 51 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: macular oedema. Novonorm dosage: 6 Mg, Qd. During the same period patient was treated with CRESTOR (5 Mg, Qd) (View Crestor Review and Crestor Label ), AVANDAMET (Unk) (View Avandamet Review and Avandamet Label ).

6480168-6 | Cytolytic Hepatitis
on Nov 27, 2009 Male patient from FRANCE , 78 years of age, was diagnosed with type 2 diabetes mellitus, hiv infection (What is hiv infection?), gout (What is gout?) and was treated with Novonorm (View Usage). Patient had the following side effects: cytolytic hepatitis. Novonorm dosage: 1 Mg, Unk. During the same period patient was treated with KALETRA /01399701/ (4 Pharmaceutical Doses) (View Kaletra /01399701/ Review and Kaletra /01399701/ Label ), KIVEXA (900 Mg, Qd) (View Kivexa Review and Kivexa Label ), ZYLORIC /00003301/ (Uk) (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ), COLCHIMAX /00728901/ (Unk) (View Colchimax /00728901/ Review and Colchimax /00728901/ Label ). Patient was hospitalized.

6480168-6 | Cytolytic Hepatitis
Patient was taking Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: cytolytic hepatitis on Nov 27, 2009 from FRANCE Additional patient health information: Male patient , 78 years of age, was diagnosed with type 2 diabetes mellitus, hiv infection (What is hiv infection?), gout (What is gout?) and. Novonorm dosage: 1 Mg, Unk. During the same period patient was treated with KALETRA (4 Pharmaceutical Doses) (View Kaletra Review and Kaletra Label ), KIVEXA (900 Mg, Qd) (View Kivexa Review and Kivexa Label ), ZYLORIC (Uk) (View Zyloric Review and Zyloric Label ), COLCHIMAX (Unk) (View Colchimax Review and Colchimax Label ). Patient was hospitalized.

6480165-0 | Dysarthria, Hypoglycaemia
Adverse event was reported on Nov 27, 2009 by a Female patient taking Novonorm (View Usage) (Dosage: 1 Mg, Tid) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 74 years of age, Patient experienced the following unwanted or unexpected effects: dysarthria, hypoglycaemia. During the same period patient was treated with COKENZEN (View Cokenzen Review and Cokenzen Label ), ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ), PREVISCAN /00261401/ (View Previscan /00261401/ Review and Previscan /00261401/ Label ), CRESTOR (View Crestor Review and Crestor Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), STABLON /00956301/ (View Stablon /00956301/ Review and Stablon /00956301/ Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6477672-3 | Pneumonia
on Nov 26, 2009 Male patient from SPAIN , 59 years of age, weighting 185.2 lb, was diagnosed with type 2 diabetes mellitus and was treated with Novonorm (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Novonorm dosage: Unk. During the same period patient was treated with PROTAPHANE PENFILL (View Protaphane Penfill Review and Protaphane Penfill Label ), ATORVASTATIN (20 Mg, Qd) (View Atorvastatin Review and Atorvastatin Label ), IRBESARTAN (150 Mg, Qd) (View Irbesartan Review and Irbesartan Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), HIDROCLOROTIAZIDE (12.5 Mg, Qd) (View Hidroclorotiazide Review and Hidroclorotiazide Label ). Patient was hospitalized.

6461123-9 | Macular Oedema
on Nov 17, 2009 Male patient from FRANCE , 51 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: macular oedema. Novonorm dosage: 6 Mg, Unk. During the same period patient was treated with CRESTOR (5 Mg, Qd) (View Crestor Review and Crestor Label ), AVANDAMET (View Avandamet Review and Avandamet Label ).

6456833-3 | Hypokalaemia, Somnolence
Patient was taking Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, somnolence on Nov 16, 2009 from FRANCE Additional patient health information: Female patient , 82 years of age, was diagnosed with type 2 diabetes mellitus and. Novonorm dosage: Uk. During the same period patient was treated with FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), METFORMIN (View Metformin Review and Metformin Label ), MEDIATOR (150 Mg, Unk) (View Mediator Review and Mediator Label ), TAREG (160 Mg, Unk) (View Tareg Review and Tareg Label ), LOXEN (20 Mg, Unk) (View Loxen Review and Loxen Label ), LEVOTHYROXINE SODIUM (125 Ug, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), KARDEGIC /00002703/ (160 Mg, Unk) (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ). Patient was hospitalized.

6428106-6 | Hypoglycaemia, Hypoglycaemic Coma, Product Counterfeit
Adverse event was reported on Oct 27, 2009 by a Male patient taking Novonorm (View Usage) (Dosage: 1 Mg, Unk) . Location: CHINA , 75 years of age, Patient had the following side effects: hypoglycaemia, hypoglycaemic coma, product counterfeit.

6410109-9 | Cardiac Failure, Lung Disorder
on Oct 15, 2009 Female patient from FRANCE , 85 years of age, weighting 105.8 lb, was treated with Novonorm (View Usage). After Novonorm was administered, patient had the following side effects: cardiac failure, lung disorder. Novonorm dosage: 1 Mg, Qd. During the same period patient was treated with MOPRAL /00661201/ (20 Mg, Qd) (View Mopral /00661201/ Review and Mopral /00661201/ Label ), TARDYFERON /00023503/ (Unk, Unk) (View Tardyferon /00023503/ Review and Tardyferon /00023503/ Label ), FORLAX (View Forlax Review and Forlax Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), TRIATEC /00885601/ (View Triatec /00885601/ Review and Triatec /00885601/ Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6384714-2 | Hypoglycaemia, Somnolence
on Sep 22, 2009 Female patient from SWITZERLAND , 86 years of age, was treated with Novonorm (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, somnolence. Novonorm dosage: 6 Mg, Qd 3x 2mg. During the same period patient was treated with LANTUS (10 Iu, Qd) (View Lantus Review and Lantus Label ), DILATREND (25 Mg, Qd (2 X 12,5 Mg)) (View Dilatrend Review and Dilatrend Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), AMLOPIN /00972401/ (View Amlopin /00972401/ Review and Amlopin /00972401/ Label ), ATACAND (View Atacand Review and Atacand Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), METOLAZONE (View Metolazone Review and Metolazone Label ). Patient was hospitalized.

6382782-5 | Asthenia, Blood Glucose Increased, Chest Discomfort, Confusional State, Fatigue, Ventricular Extrasystoles
Patient was taking Novonorm (View Usage). Patient had the following side effects: asthenia, blood glucose increased, chest discomfort, confusional state, fatigue, ventricular extrasystoles on Sep 02, 2008 from CHINA Additional patient health information: Male patient , 64 years of age, was diagnosed with type 2 diabetes mellitus and. Novonorm dosage: 1.5 Mg.